Question Title

* 1. What is your specific interest in immuno-oncology?

Question Title

* 2. What, if any, do you feel are the key benefits associated with cancer immunotherapies? Please select all responses that apply.

Question Title

* 3. In your opinion, which immunotherapy combination has the most clinical potential?

Question Title

* 4. What, if any, do you see as the key limitation of current cancer immunotherapies?

Question Title

* 5. What is the biggest challenge in developing novel and effective immunotherapies to treat cancer?

Question Title

* 6. Assuming that CME courses, conferences and journal publications are primary channels to stay informed on advances in immunotherapy and diagnostic tests. Please rank these additional opportunities (1 being most important) in order of importance for you to stay up-to-date

Question Title

* 7. How would you rate your patient’s receptivity to cancer immunotherapies as a treatment option?

Question Title

* 8. What percentage of your patients currently being treated with pharmacological therapy are receiving an immunotherapy?

Question Title

* 9. In 5 years, what percentage of your pharmacologically treated patients do you estimate will be receiving an immunotherapy?

Question Title

* 10. In your opinion, do current immunotherapies offer good value in terms of cost per quality adjusted life year? Please explain your reasoning

0 of 18 answered
 

T